From Science to Strategy

Personalized, High-Impact Partnership

Lucerna Via partners with neuroscience innovators at every stage of development, helping early-stage teams translate strong science into actionable clinical strategies and supporting established companies expanding into neurotherapeutics with focused, evidence-based insight. Every engagement is tailored to your company’s specific challenges and objectives, delivering guidance that is scientifically rigorous, commercially informed, and aligned with regulatory requirements. The result is practical, actionable strategies that move programs efficiently toward approval and market success.

Why Neuroscience Is Different

Clinical development in neuroscience presents unique challenges, from the subjectivity of endpoints and high placebo responses to slow disease progression and patient recruitment hurdles. Lucerna Via brings specialized experience across these complexities, helping teams design feasible, meaningful studies that deliver measurable impact. We understand where biology, behavior, and regulatory science intersect, and apply practical strategies that balance scientific ambition with operational reality.

Science-Driven, Strategy Focused

We combine scientific depth with strategic clarity, working as an extension of your team to deliver hands-on support where it matters most. Our role is to listen, adapt, and apply evidence-based insight that moves your neurotherapeutic development program forward. Whether collaborating on protocol design, refining communication plans, or shaping broader clinical strategy, we integrate seamlessly with your workflow to drive meaningful progress.

Collaborative Partnership

We see ourselves as an extension of your team, providing experienced insight and hands-on support when and where you need it most. Our role is to listen, adapt, and deliver insights that move your neurotherapeutic development program forward. Whether collaborating on protocol design, strengthening communication plans, or shaping broader clinical strategy, we integrate seamlessly with your workflow to drive meaningful progress.

The Cost of Time in Neurotherapeutic Development

Developing a new neurotherapeutic is a long and complex journey, often taking 12 to 15 years from patent to approval. For early-stage companies, every delay matters. Each added month increases costs, consumes limited runway, and shortens the period of potential market exclusivity. Lucerna Via helps teams anticipate and prevent the bottlenecks that commonly extend timelines. By aligning scientific design with regulatory expectations and operational feasibility, we help clients make informed decisions that preserve both time and value. Our goal is to position programs for steady, efficient progress and generate the kind of evidence that supports success in later development, partnership discussions, and beyond.

Focused on Outcomes

Every project begins with a core question: How will this create meaningful impact?

For us, impact means accelerating innovation, strengthening trial outcomes, and positioning programs for regulatory, investor, and payer confidence. By uniting science with market strategy, we help you maximize resources, mitigate risk, and build a clear path to commercialization—so promising therapies can reach the patients who need them most.